Madeline King, PharmD, BCIDP

home / authors / madeline-king-pharmd-bcidp

King is an infectious diseases PGY2 residency program director, codirector of outpatient antimicrobial stewardship, and outpatient infectious diseases clinical pharmacist at Cooper University Hospital in Camden, New Jersey.

Articles

Do You Have a Minute? Asking Infectious Diseases Clinicians to Provide Uncompensated Services

Do You Have a Minute? Asking Infectious Diseases Clinicians to Provide Uncompensated Services

Madeline King, PharmD, BCIDP
November 1st 2024

ID clinicians must be paid for time spent conducting unbillable work for OPAT services.

Read More

Site Logo

Future of Fluoroquinolones: Risks, Benefits of Antibiotic Workhorse

Lucia Rose, PharmD, BCIDP;Madeline King, PharmD, BCIDP
April 8th 2019

Warnings and concerns regarding fluoroquinolones are on the rise, but the antibiotics still play a role, albeit more limited, in the treatment of various infectious diseases.

Read More

Latest Updated Articles

Concerns Over Mosquito-Borne Illness Causes Massachusetts Town to Create Curfew for Parks, Spraying in Counties
Published: August 27th 2024 | Updated: August 28th 2024
Concerns Over Mosquito-Borne Illness Causes Massachusetts Town to Create Curfew for Parks, Spraying in Counties
Merck’s MK-8527 Advances to Phase 3 for Once-Monthly HIV Prevention
Published: July 15th 2025 | Updated: July 19th 2025
Merck’s MK-8527 Advances to Phase 3 for Once-Monthly HIV Prevention
TAXIS Pharmaceuticals Earns FDA QIDP Designation for Its Efflux Pump Inhibitor for Pneumonia
Published: July 15th 2025 | Updated: July 19th 2025
TAXIS Pharmaceuticals Earns FDA QIDP Designation for Its Efflux Pump Inhibitor for Pneumonia
Study Results Find AMR Policy Messaging Misses the Mark With Agricultural Stakeholders
Published: July 15th 2025 | Updated: July 19th 2025
Study Results Find AMR Policy Messaging Misses the Mark With Agricultural Stakeholders
FDA Approves Prefilled Syringe Presentation of GSK’s Shingrix for Shingles Prevention
Published: July 17th 2025 | Updated: July 19th 2025
FDA Approves Prefilled Syringe Presentation of GSK’s Shingrix for Shingles Prevention
Findings From Screening Study for Hepatitis B and Hepatitis D Demonstrate Need for Follow-Up Testing
Published: July 15th 2025 | Updated: July 19th 2025
Findings From Screening Study for Hepatitis B and Hepatitis D Demonstrate Need for Follow-Up Testing
© 2025 MJH Life Sciences

All rights reserved.